Identification of HLA-DPA1*01:03:01:57 and HLA-DPA1*02:01:01:29 from a case–control study of atopic dermatitis
Funding information Children's Hospital of Philadelphia; National Institutes of Health; Perelman School of Medicine, University of Pennsylvania
Abstract
DPA1*01:03:01:57 and DPA1*02:01:01:29 differ by a single nucleotide from their closest references, DPA1*01:03:01:02 and DPA1*02:01:01:06.
CONFLICT OF INTEREST
Jamie L. Duke and Dimitri S. Monos receive royalties from Omixon. Dimitri S. Monos is also the Chair of the Scientific Advisory Board of Omixon and owns options in Omixon. David J. Margolis is or recently has been a consultant for Pfizer, Leo, and Sanofi with respect to studies of atopic dermatitis and served on an advisory board for the National Eczema Association.
Open Research
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are openly available in IPD-IMGT/HLA at https://www.ebi.ac.uk/ipd/imgt/hla/, reference number HLA34360 and HLA34329.
